Ledger.
Investor · White Plains, NY

Robert J. Deluccia

Open Robert in the network graph →
Filings
33
SEC Form D
Connections
132
co-filers
Capital
$17.1M
across filings
Active
Jun 2017
to Jan 2020

Most-connected co-filers (132)

David P. Luci · White Plains, NY19 sharedRobert G. Shawah · White Plains, NY13 sharedMorris T. Marcus · AUSTIN, TX9 sharedKeith W. Pennell · New York, NY9 sharedCarl H. Sailer · Staten Island, NY7 sharedThomas H. Harrison · Staten Island, NY6 sharedJoanna Riley · San Francisco, CA5 sharedJohn G. Terrana · White Plains, NY5 sharedJeffrey C. Seller · New York, NY5 sharedRon Storn · San Francisco, CA5 sharedUllas Naik · SAN FRANCISCO, CA5 sharedThomas Lazay · Cambridge, MA5 sharedFiras Raouf · Boston, MA5 sharedScott Horner · Radford, VA4 sharedJoseph H. Scodari · Staten Island, NY4 sharedJames H. Donohue · Staten Island, NY4 sharedWilliam J. Mcsherry, Jr · White Plains, NY4 sharedPatrick J. Meagher · Vancouver, British Columbia, Canada4 sharedErik S. Nelson · Atlanta, GA4 sharedScott Bader · Minneapolis, MN4 sharedSid Bader · Minneapolis, MN4 sharedLowell D. Ness · Palo Alto, CA4 sharedJack H. Dean · Staten Island, NY4 sharedJack Dean · White Plains, NY4 shared

Recent filings (33)

Acurx Pharmaceuticals, Inc.Jun 2025 · 15 co-filers$4.0MAcurx Pharmaceuticals, Inc.Jun 2025 · 15 co-filers$4.0MAcurx Pharmaceuticals, Inc.May 2025 · 23 co-filers$12.0MAcurx Pharmaceuticals, Inc.May 2025 · 23 co-filers$12.0MAcurx Pharmaceuticals, Inc.Mar 2025 · 23 co-filers$3.4MAcurx Pharmaceuticals, Inc.Mar 2025 · 23 co-filers$3.4MPreciTaste Inc.Mar 2025 · 20 co-filers$20.0MAcurx Pharmaceuticals, Inc.Jan 2025 · 23 co-filers$2.4MAcurx Pharmaceuticals, Inc.Jan 2025 · 23 co-filers$2.4MPreciTaste Inc.Jul 2024 · 20 co-filers$6.0MEVERGEN EQUITY 17, LPMay 2024 · 4 co-filers$2.3MEVERGEN EQUITY 16, LPApr 2024 · 4 co-filers$7.1MEvergen Coinvestment Vehicle I, LPApr 2024 · 6 co-filers$20.0MPlus None, Inc.Jan 2024 · 11 co-filers$2.0MEVERGEN EQUITY 15, LPOct 2023 · 4 co-filers$1.5MEvergen Equity 12, LPOct 2023 · 4 co-filers$840KEVERGEN EQUITY 13 LIMITED PARTNERSHIPSep 2023 · 4 co-filers$1.6MEVERGEN EQUITY 11, LPSep 2023 · 4 co-filers$6.5MEvergen Equity 10, LPJun 2023 · 4 co-filers$2.5MEvergen Equity 9, LPMar 2023 · 4 co-filers$3.1MPlus None, Inc.Mar 2023 · 11 co-filers$500KAcurx Pharmaceuticals, LLCJan 2020 · 22 co-filers$6.0MAcurx Pharmaceuticals, LLCOct 2019 · 8 co-filers$7.8MAcurx Pharmaceuticals, LLCOct 2018 · 8 co-filers$7.0MAcurx Pharmaceuticals, LLCMay 2018 · 8 co-filers$7.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Robert in the interactive graph →